The Effects of Electroacupuncture on the Apelin/APJ System in the Spinal Cord of Rats With Inflammatory Pain
Authors:
- Ke WangKWKe Wang
- Ziyong JuZJZiyong Ju
- Yue YongYYYue Yong
- Tongyu ChenTCTongyu Chen
- Jiangang SongJSJiangang Song
- Jia ZhouJZJia Zhou
- 1 December 2016
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 123 (6) , 1603-1610
Abstract
Electroacupuncture (EA) is widely applied for pain management, but the analgesic effects of EA have not been fully elucidated. In this study, we investigated the effect of EA on inflammatory pain caused by intraplantar injection of complete Freund’s adjuvant (CFA) and apelin/APJ expression in the spinal cord of rats. The study was conducted in 3 parts. In part 1, Sprague-Dawley rats were divided into 4 groups (n = 10): sham, CFA, EA (CFA + 2 Hz EA at acupoints), and NA-EA (CFA + acupuncture without electrical stimulation). The time courses of mechanical and thermal sensitivity were determined. The protein and messenger RNA (mRNA) levels of apelin and APJ in the spinal cord were assayed by Western blotting and real-time polymerase chain reaction, respectively. In part 2, the rats were divided into 5 groups (n = 7–8): sham, CFA, EA, F13A (CFA + intrathecal injection of F13A), and EA-F13A (CFA + EA + intrathecal injection of F13A). In part 3, the rats were divided into 5 groups (n = 8): sham, CFA, EA, apelin-13 (CFA + intrathecal injection of apelin-13), and EA + apelin-13 (CFA + EA + intrathecal injection of apelin-13). EA treatment exhibited significant antinociceptive effects (mechanical sensitivity: mean difference [99% confidence interval {CI}]: 5.86 [4.96–6.77]; thermal sensitivity: mean difference [99% CI]: 2.45 [0.91–4.00]; EA versus CFA) and mitigated the CFA-induced reduction of apelin and APJ protein and mRNA expression in the spinal cord. Furthermore, intrathecal injection of the apelin/APJ system antagonist F13A blocked the analgesic effect of EA (mechanical sensitivity: mean difference [99% CI]: 8.99 [5.81–12.17]; thermal sensitivity: mean difference [99% CI]: 4.22 [1.33–7.12]; EA versus EA-F13A). When EA was combined with apelin-13 through intrathecal administration, it was more potent in reducing mechanical allodynia (mean difference [99% CI]: 5.98 [2.38–9.57], EA + apelin-13 versus apelin-13; mean difference [99% CI]: 4.29 [0.72–7.87], EA + apelin-13 versus EA) and thermal hyperalgesia (mean difference [99% CI]: 5.23 [2.19–8.28], EA + apelin-13 versus apelin-13; mean difference [99% CI]: 6.43 [3.38–9.48], EA + apelin-13 versus EA). EA stimulation could alleviate inflammatory pain, at least in part, by restoring apelin and APJ mRNA and protein expression levels, which are downregulated in the CFA pain model.Keywords
This publication has 30 references indexed in Scilit:
- The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCRBiochemistry and Cell Biology, 2014
- Side Effects of Commonly Prescribed Analgesic MedicationsPhysical Medicine and Rehabilitation Clinics of North America, 2014
- The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasisJournal of Endocrinology, 2013
- Treatment Satisfaction in Osteoarthritis and Chronic Low Back Pain: The Role of Pain, Physical and Emotional Functioning, Sleep, and Adverse EventsThe Journal of Pain, 2011
- Central mechanisms of pathological painNature Medicine, 2010
- The apelinergic system: a promising therapeutic targetExpert Opinion on Therapeutic Targets, 2010
- Expanding role for the apelin/APJ system in physiopathologyJournal of Physiology and Biochemistry, 2007
- Role of the Immune system in chronic painNature Reviews Neuroscience, 2005
- Molecular cloning and expression of aminopeptidase A isoforms from rat hippocampusBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2000
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998